We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

197 hedge funds and large institutions have $1.13B invested in Myriad Genetics in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 66 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,953% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $43K

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

11% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 66

3% more funds holding

Funds holding: 191 → 197 (+6)

1.54% less ownership

Funds ownership: 101.06% → 99.52% (-1.5%)

27% less capital invested

Capital invested by funds: $1.55B → $1.13B (-$423M)

Holders
197
Holders Change
+6
Holders Change %
+3.14%
% of All Funds
3.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
73
Reduced
66
Closed
20
Calls
$1.31M
Puts
$43K
Net Calls
+$1.27M
Net Calls Change
-$859K

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$37.3M
2
GCM
Glenview Capital Management
New York
+$30.5M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$15.4M
4
Invesco
Invesco
Georgia
+$7.05M
5
State Street
State Street
Massachusetts
+$6.77M

Top Sellers

Rank Fund Capital Flow
1
EARNEST Partners
EARNEST Partners
Georgia
-$60.9M
2
PHS
PFM Health Sciences
California
-$14.2M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$13.1M
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$12.6M
5
Artisan Partners
Artisan Partners
Wisconsin
-$8.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMS
26
Pictet Asset Management (Switzerland)
Switzerland
$4.36M +$1.47M +78,881 +36%
PAMP
27
Polar Asset Management Partners
Ontario, Canada
$3.95M -$13.1M -702,800 -72%
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$3.74M +$206K +11,059 +4%
N
29
Nuveen
North Carolina
$3.62M -$690K -37,016 -13%
Legal & General Group
30
Legal & General Group
United Kingdom
$3.53M +$114K +6,106 +3%
Wells Fargo
31
Wells Fargo
California
$3.52M -$2.09M -112,175 -32%
ACM
32
Altium Capital Management
New York
$3.08M +$484K +26,000 +14%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$2.99M +$653K +35,049 +20%
Swiss National Bank
34
Swiss National Bank
Switzerland
$2.83M +$78.3K +4,200 +2%
Fisher Asset Management
35
Fisher Asset Management
Washington
$2.76M +$1.2M +64,276 +51%
UBS Group
36
UBS Group
Switzerland
$2.67M +$2.78M +149,281 +429%
CS
37
Credit Suisse
Switzerland
$2.63M +$1.03M +55,193 +44%
Nordea Investment Management
38
Nordea Investment Management
Sweden
$2.56M -$356K -19,096 -9%
Squarepoint
39
Squarepoint
New York
$2.41M +$2.62M +140,496 +543%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$2.4M -$12.6M -677,809 -80%
LCM
41
Landscape Capital Management
New Jersey
$2.22M +$2.85M +152,773 New
Public Sector Pension Investment Board (PSP Investments)
42
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.14M – – –
Marshall Wace
43
Marshall Wace
United Kingdom
$2.13M +$2.74M +147,004 New
Envestnet Asset Management
44
Envestnet Asset Management
Illinois
$2.09M -$196K -10,507 -7%
Citigroup
45
Citigroup
New York
$2.06M -$1.03M -55,320 -28%
Barclays
46
Barclays
United Kingdom
$2.05M +$134K +7,203 +5%
JP Morgan Chase
47
JP Morgan Chase
New York
$2.04M -$400K -21,467 -13%
Macquarie Group
48
Macquarie Group
Australia
$1.96M -$14.6K -784 -0.6%
LM
49
Luminus Management
Texas
$1.78M +$2.29M +122,691 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.74M +$34.1K +1,830 +2%
1
2
3 4 5

MYGN Hedge Fund Activity: Q4 2022 in Review

197 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q4 2022, worth a combined $1.13B — down 27% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new MYGN positions and 20 closed out — a net gain of 9 holders — while 73 added to existing stakes and 66 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $37.3M. The largest seller was EARNEST Partners, cutting an estimated $60.9M.

  • 197 institutional investors held Myriad Genetics (MYGN) as of Q4 2022, up from 191 in Q3 2022.
  • Funds reported $1.13B of Myriad Genetics stock for Q4 2022, down 27% quarter-over-quarter.
  • 29 funds opened new Myriad Genetics positions in Q4 2022 and 20 closed out, a net change of +9 holders.
  • The largest Myriad Genetics buyer in Q4 2022 was Camber Capital Management, an estimated $37.3M added.
  • The largest Myriad Genetics seller in Q4 2022 was EARNEST Partners, an estimated $60.9M sold.

Based on aggregated 13F filings for Q4 2022.